Seeing Is Believing
LXEO is currently covered by 6 analysts with an average price target of $15.5. This is a potential upside of $9.07 (227%) from yesterday's end of day stock price of $4.74.
Lexeo Therapeutics, Common Stock's activity chart (see below) currently has 39 price targets and 42 ratings on display. The stock rating distribution of LXEO is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 7.14% with an average time for these price targets to be met of 30.71 days.
Highest price target for LXEO is $20, Lowest price target is $9, average price target is $15.5.
Most recent stock forecast was given by from JPMORGAN on 25-Jun-2026. First documented stock forecast 27-Nov-2023.
Currently out of the existing stock ratings of LXEO, 13 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 28-Nov-2023
$9
$4.25 (89.47%)
$10
21 days ago
(25-Jun-2026)
1/3 (33.33%)
$4.3 (91.49%)
151
Buy Since 28-Nov-2023
$17
$12.25 (257.89%)
$17
2 months 5 days ago
(11-May-2026)
0/7 (0%)
$10.88 (177.78%)
Buy Since 06-Jun-2024
$10
$5.25 (110.53%)
$13
6 months 3 days ago
(13-Jan-2026)
0/11 (0%)
$2.57 (34.59%)
Buy Since 20-Nov-2025
$19
$14.25 (300.00%)
$19
7 months 15 days ago
(01-Dec-2025)
0/2 (0%)
$10.08 (113.00%)
Buy Since 28-Nov-2023
$18
$13.25 (278.95%)
$21
8 months 29 days ago
(17-Oct-2025)
0/4 (0%)
$8.42 (87.89%)
What is LXEO (Lexeo Therapeutics, Common Stock) average time for price targets to be met?
Which analyst has the current highest performing score on LXEO (Lexeo Therapeutics, Common Stock) with a proven track record?
Which analyst has the most public recommendations on LXEO (Lexeo Therapeutics, Common Stock)?
Which analyst is the currently most bullish on LXEO (Lexeo Therapeutics, Common Stock)?
Which analyst is the currently most reserved on LXEO (Lexeo Therapeutics, Common Stock)?